HomeWXIBF • OTCMKTS
WuXi Biologics (Cayman) Inc
$1.86
Nov 27, 12:20:57 AM GMT-5 · USD · OTCMKTS · Disclaimer
StockUS listed security
Previous close
$1.86
Year range
$1.30 - $5.34
Market cap
61.41B HKD
Avg Volume
32.00
P/E ratio
-
Dividend yield
-
Primary exchange
HKG
CDP Climate Change Score
A-
Market news
Financials
Income Statement
Revenue
Net income
(CNY)Jun 2024Y/Y change
Revenue
4.29B0.97%
Operating expense
765.14M21.62%
Net income
749.54M-33.86%
Net profit margin
17.48-34.51%
Earnings per share
EBITDA
1.24B-13.32%
Effective tax rate
11.36%
Total assets
Total liabilities
(CNY)Jun 2024Y/Y change
Cash and short-term investments
9.53B9.60%
Total assets
56.11B7.60%
Total liabilities
11.46B-12.46%
Total equity
44.64B
Shares outstanding
4.15B
Price to book
0.19
Return on assets
4.05%
Return on capital
4.62%
Net change in cash
(CNY)Jun 2024Y/Y change
Net income
749.54M-33.86%
Cash from operations
651.06M-52.65%
Cash from investing
-191.26M75.93%
Cash from financing
-737.79M-684.70%
Net change in cash
-258.16M-153.79%
Free cash flow
350.65M52.56%
About
WuXi Biologics is a global Contract Research Development and Manufacturing Organization that provides open-access, integrated technology platforms for biologics drug development. WuXi Biologics' roots date back to 2010, and began building out capabilities and facilities required for biologics discovery, development and GMP manufacturing. WuXi Biologics went public on the Hong Kong Stock Exchange in June 2017. As of 2021, WuXi Biologics has 18 manufacturing sites including ten in China, three in the United States, two in Ireland, two in Germany, and one in Singapore. In August 2020, WuXi Biologics was selected to become a component of the Hang Seng Index in Hong Kong. In January 2024, WuXi Biologics' share price fell on news that the United States Congress had introduced legislation to block any federal government contracts with the company due to national security concerns. The concerns stem from allegations, denied by the company, that it has worked closely with the People's Liberation Army as a part of the Chinese Communist Party's military-civil fusion strategy. Wikipedia
Founded
2010
Employees
12,435
Discover more
You may be interested in
This list is generated from recent searches, followed securities, and other activity. Learn more

All data and information is provided “as is” for personal informational purposes only, and is not intended to be financial advice nor is it for trading purposes or investment, tax, legal, accounting or other advice. Google is not an investment adviser nor is it a financial adviser and expresses no view, recommendation or opinion with respect to any of the companies included in this list or any securities issued by those companies. Please consult your broker or financial representative to verify pricing before executing any trades. Learn more
People also search for
Search
Clear search
Close search
Google apps
Main menu